APA (7th ed.) Citation

Patel, A. D., Mazurkiewicz‐Bełdzińska, M., Chin, R. F., Gil‐Nagel, A., Gunning, B., Halford, J. J., . . . Devinsky, O. (2021). Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial. Epilepsia (Copenhagen), 62(9), 2228-2239. https://doi.org/10.1111/epi.17000

Chicago Style (17th ed.) Citation

Patel, Anup D., et al. "Long‐term Safety and Efficacy of Add‐on Cannabidiol in Patients with Lennox–Gastaut Syndrome: Results of a Long‐term Open‐label Extension Trial." Epilepsia (Copenhagen) 62, no. 9 (2021): 2228-2239. https://doi.org/10.1111/epi.17000.

MLA (9th ed.) Citation

Patel, Anup D., et al. "Long‐term Safety and Efficacy of Add‐on Cannabidiol in Patients with Lennox–Gastaut Syndrome: Results of a Long‐term Open‐label Extension Trial." Epilepsia (Copenhagen), vol. 62, no. 9, 2021, pp. 2228-2239, https://doi.org/10.1111/epi.17000.